ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Clinical and biochemical features of growth hormone insensitivity syndromes

Clinical and biochemical features of growth hormone insensitivity syndromes
Syndrome Clinical features GH GHBP IGF-1 IGFBP-3 ALS Treatment MIM
GH receptor mutations (classic Laron syndrome) Postnatal growth failure, infantile facies, abnormal body composition. Mediterranean or Middle Eastern ancestry is common*. N or

(if mutation affects extracellular domain of the GH receptor)

Otherwise N or
rIGF-1 262500
Abnormal GH receptor signal transduction (STAT5b mutation) Postnatal growth failure, immune dysregulation. N or N rIGF-1 245590
IGF1 gene mutation (partial loss of function) Marked prenatal growth failure; postnatal growth failure, neurocognitive defects, sensorineural hearing loss. N or N N rIGF-1 608747
Defective stabilization of circulating IGF-1 (ALS deficiency) Mild postnatal growth failure, usually delayed puberty. N or N ? rIGF-1 615961
IGF-1 receptor mutation (partial loss of function or tissue-specific defect) Pre- and postnatal growth failure, delayed bone maturation, variable phenotype. N or N N or N ? 270450

GH: growth hormone; GHBP: growth hormone-binding protein; IGF-1: insulin-like growth factor 1; IGFBP-3: insulin-like growth factor-binding protein 3; ALS: acid-labile subunit; MIM: Mendelian Inheritance in Man database (National Institutes of Health); N: normal levels; rIGF-1: recombinant insulin-like growth factor 1 (mecasermin); STAT5b: signal transducer and activator of transcription 5B gene; IGF1: insulin-like growth factor 1 gene.

* This includes a population with Laron syndrome in Ecuador, with Mediterranean (Spanish) ancestry.
Graphic 62441 Version 11.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟